Source:http://linkedlifedata.com/resource/pubmed/id/20688930
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
10
|
pubmed:dateCreated |
2010-10-4
|
pubmed:abstractText |
Inflammation significantly contributes to the progression of chronic kidney disease (CKD). Inflammasome-dependent cytokines, such as IL-1? and IL-18, play a role in CKD, but their regulation during renal injury is unknown. Here, we analyzed the processing of caspase-1, IL-1?, and IL-18 after unilateral ureteral obstruction (UUO) in mice, which suggested activation of the Nlrp3 inflammasome during renal injury. Compared with wild-type mice, Nlrp3(-/-) mice had less tubular injury, inflammation, and fibrosis after UUO, associated with a reduction in caspase-1 activation and maturation of IL-1? and IL-18; these data confirm that the Nlrp3 inflammasome upregulates these cytokines in the kidney during injury. Bone marrow chimeras revealed that Nlrp3 mediates the injurious/inflammatory processes in both hematopoietic and nonhematopoietic cellular compartments. In tissue from human renal biopsies, a wide variety of nondiabetic kidney diseases exhibited increased expression of NLRP3 mRNA, which correlated with renal function. Taken together, these results strongly support a role for NLRP3 in renal injury and identify the inflammasome as a possible therapeutic target in the treatment of patients with progressive CKD.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
1533-3450
|
pubmed:author |
pubmed-author:BeckPaul LPL,
pubmed-author:ChinRickR,
pubmed-author:ChunJustinJ,
pubmed-author:ClarkSharon ASA,
pubmed-author:HemmelgarnBrenda RBR,
pubmed-author:HirotaSimonS,
pubmed-author:LiYanY,
pubmed-author:MuruveDaniel ADA,
pubmed-author:SeamoneMark EME,
pubmed-author:TrpkovKirilK,
pubmed-author:TschoppJurgJ,
pubmed-author:VilaysaneAkosuaA,
pubmed-author:WangWenjieW
|
pubmed:issnType |
Electronic
|
pubmed:volume |
21
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1732-44
|
pubmed:dateRevised |
2011-10-3
|
pubmed:meshHeading |
pubmed-meshheading:20688930-Animals,
pubmed-meshheading:20688930-Carrier Proteins,
pubmed-meshheading:20688930-Cells, Cultured,
pubmed-meshheading:20688930-Fibrosis,
pubmed-meshheading:20688930-Humans,
pubmed-meshheading:20688930-Kidney,
pubmed-meshheading:20688930-Male,
pubmed-meshheading:20688930-Mice,
pubmed-meshheading:20688930-Mice, Inbred C57BL,
pubmed-meshheading:20688930-Nephritis,
pubmed-meshheading:20688930-RNA, Messenger,
pubmed-meshheading:20688930-Renal Insufficiency, Chronic,
pubmed-meshheading:20688930-Ureteral Obstruction
|
pubmed:year |
2010
|
pubmed:articleTitle |
The NLRP3 inflammasome promotes renal inflammation and contributes to CKD.
|
pubmed:affiliation |
Department of Medicine, University of Calgary, Calgary, Alberta, Canada.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|